CardioKinetix Announces the 500th Parachute Heart Failure Device Implantation July 21, 2016 Menlo Park, Calif. – July 21, 2016— CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced that 500 patients have...
Bio-Techne Announces Agreement to Acquire Advanceed Cell Diagnostics July 06, 2016 Minneapolis/July 6, 2016/–Bio-Techne Corporation (NASDAQ: TECH) announced today that it has agreed to acquire Advanced Cell Diagnostics (ACD) for $250 million in cash plus...
CRISPR Therapeutics Raises Additional $38M as Part of Series B Financing Funding to Support the Development of its CRISPR/Cas9 Gene-Editing Platform and Programs BASEL, Switzerland and Cambridge, Massachusetts – CRISPR Therapeutics, a biopharmaceutical company focused...
Unum Therapeutics Announces Active Investigational New Drug (IND) Application for ACTR087 in Patients with Relapsed/Refractory B-cell Lymphoma Company Focused on Initiating Multi-center, Phase 1 Trial in Second Half of 2016 – CAMBRIDGE, MA, June 20, 2016 – a...
Kit Check Closes $15 Million Series C Round Baxter Ventures Leads Round; Black Granite Capital, Kaiser Permanente Ventures, Rex Health Ventures, New Leaf Venture Partners, Easton Capital Management, LionBird and Sands Capital Ventures Participate Kit...
Recent Comments